ברקע: סכרת מסוג II, ידועה 20 שנה, אינה מאוזנת היטב מחלת לב איסכמית, עברה אוטם שריר הלב לפני 5 שנים עישון של חפיסת סיגריות ליום מזה 40 שנה בחודשים האחרונים שמה לב לנפיחות גוברת ברגליים, נפיחות בבטן וקוצר נשימה במאמצים קלים. עלתה 7 ק"ג במשקלה ב- 3 החודשים האחרונים. מ.כ., בת 65
Approach to the adult with edema Ilan Krause Dept. of Medicine E Rabin Medical Center, Beilinson Hospital
Palpable swelling produced by expansion of the interstitial fluid volume several litersThe expansion takes several liters before overt manifestations of edema (i.e. weight gain of several kg.) Massive and generalized edema = Anasarca Edema
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2 Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G. Interleukin-2 therapy H. Malignant ascites Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Ernest Henry Starling
PATHOPHYSIOLOGY Alteration in capillary hemodynamics movement of fluid from vascular space into the interstitium. increased capillary hydrostatic pressure
Ernest Henry Starling
PATHOPHYSIOLOGY Alteration in capillary hemodynamics movement of fluid from vascular space into the interstitium. decreased capillary oncotic pressure increased capillary hydrostatic pressure
Ernest Henry Starling
PATHOPHYSIOLOGY Alteration in capillary hemodynamics movement of fluid from vascular space into the interstitium. increased capillary hydrostatic pressure decreased capillary oncotic pressure increased capillary permeability
The three most important causes of edema Right-sided heart failure Nephrotic-range proteinuria Cirrhosis
Right Heart Failure Increased venous pressure behind the right side of the heart increased capillary hydrostatic pressure –Congested jugular veins –Enlarged & tender liver –Peripheral edema Anasarca –Shortness of breath
Cirrhosis Increased venous pressure below the diseased liver Ascites edema in the lower extremities. Signs of portal hypertension (distended abdominal wall veins & splenomegaly) Primary liver disease vs. Cardiac cirrhosis
Nephrotic syndrome Heavy proteinuria (> 3.0 g/day) Hypoalbuminemia Hyperlipidemia Peripheral edema
Edema in Nephrotic syndrome 2 factors: 1.sodium retention due to underlying renal disease 2.diminished transcapillary oncotic pressure gradient Typically- periorbital and peripheral edema, occasionally also ascites
Other causes of Edema
Venous insufficiency limited to the lower extremities may be unilateral postphlebitic syndrome poor response to diuretics
Drug-induced edema NSAIDs Antihypertensive agents –Calcium channel antagonists –Minoxidil –Hydralazine –Clonidine –Methyldopa Glucocorticoids Anabolic steroids Estrogens Progestins Cyclosporine Growth hormone Interleukin 2
Premenstrual edema Retention of water and increase in weight which occurs during or preceding menstruation. The etiology is poorly understood The edema tends to be generalized, and resolves during a diuresis that occurs with the onset of menses.
Idiopathic edema Young women (usually obese) No cardiac, hepatic, or renal disease Periodic episodes of edema (unrelated to menstrual cycle) Orthostatic retention of sodium and water Frequently accompanied by abdominal distention Pathogenesis- unknown (capillary leak? diuretic-induced edema?) Treatment: low-sodium diet stop diuretic therapy
Nonpitting edema Lymphedema Pretibial myxedema Post mastectomy Lymphatic disease Malignancy Infection thyroid diseases
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G Interleukin-2 therapy H. Malignant ascites Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema
Increased capillary hydrostatic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G Interleukin-2 therapy H. Malignant ascites Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Clinical conditions associated with the development of edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition
Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G Interleukin-2 therapy H. Malignant ascites Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Clinical conditions associated with the development of edema Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G. Interleukin-2 therapy H. Malignant ascites
Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G. Interleukin-2 therapy H. Malignant ascites
Clinical conditions associated with the development of edema Increased capillary hydraulic pressure A. Increased plasma volume due to renal Na+ retention 1. Heart failure, including cor pulmonale 2. Primary renal sodium retention a. Renal disease, including nephrotic syndrome b. Drugs: minoxidil, NSAIDS, estrogens c. Early hepatic cirrhosis 3. Pregnancy and premenstrual edema B. Venous obstruction 1. Cirrhosis or hepatic venous obstruction 2. Local venous obstruction C. Decreased arteriolar resistance 1. Calcium channel blockers 2. Idiopathic edema Hypoalbuminemia A. Protein loss 1. Nephrotic syndrome 2. Protein-losing enteropathy B. Reduced albumin synthesis 1. Liver disease 2. Malnutrition Increased capillary permeability A. Idiopathic edema B. Burns C. Trauma D. Inflammation or sepsis E. Allergic reactions, F. Diabetes mellitus G Interleukin-2 therapy H. Malignant ascites Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Clinical conditions associated with the development of edema Lymphatic obstruction or interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
Lymphatic obstruction or increased interstitial oncotic pressure A. Postmastectomy B. Nodal enlargement due to malignancy C. Hypothyroidism D. Malignant ascites
History taking
Any disorder or drug that can cause cardiac, hepatic, or renal disease (IHD, COPD, HTN, alcohol abuse etc.) Is the edema intermittent or persistent? Where is the edema located?
Physical examination
Pitting vs. non-pitting Distribution of the edema Localized or diffuse ? Periorbital ? Jugular veins ? Ascites ? Legs Stigmata of chronic liver disease Physical findings of heart failure
Further evaluation Chest X rays Cardiomegally? Pulmonary congestion? Pleural effusion?
Further evaluation Echocardiography Chest X rays Wall motion abnormalities LV function RV function Pulmonary hypertension ?
Further evaluation Abdominal US Chest X rays Echocardiography Liver size & morphology Hepatic veins Presence of ascites Renal morphology
Further evaluation 24h urinary protein excretion Levels of liver enzymes, INR, albumin Chest X rays Echocardiography Abdominal US
Principals of therapy Reversal of the underlying disorder (if possible, but usually not) Dietary sodium restriction Diuretic therapy Only for pitting edema!
Before initiating diuretics, consider the following questions: When must edema be treated? What are the consequences of the removal of edema fluid? How rapidly should edema fluid be removed?
When must edema be treated? Almost never !
What are the consequences of the removal of edema fluid? Sodium and water retention by the kidney is compensatory! – it raises the effective circulating volume. Diuretic therapy may have a deleterious effect on systemic hemodynamics even though it reduces the edema!! Therefore- use diuretics, but cautiously ! monitoring the Urea and creatinine concentration
Use of Diuretics Start with a loop diuretic (furosemide) Watch for electrolyte complications: –Hypokalemia –Hyponatremia –Metabolic alkalosis For resistant edema- –Use high-dose intravenous loop diuretics – Use combination of diuretics to act at different sites in the nephron Thiazides, Spironolactone
Diuretic dose Dose-response curve Diuresis begins with as little as 10 mg of fusid, with maximal effect at IV 40 mg. The effective dose is higher in CHF, advanced cirrhosis, or renal failure, due to decreased renal perfusion.
Intravenous vs. oral therapy Onset of diuresis is earlier and the peak diuresis is greater with IV therapy This difference is not likely to be important in stable patients The intravenous equivalent for Fusid is one-half the oral dose
Special considerations NS Cirrhosis Higher than usual doses of a loop diuretic may be required Renal failure Binding of the loop diuretic by albumin in the tubular lumen
Special considerations NS Cirrhosis Spironolactone is the preferred initial diuretic The diuresis should proceed very slowly ! In patients with tense ascites, consider paracentesis
בת 65 ברקע: סכרת מסוג II, ידועה 20 שנה, אינה מאוזנת היטב מחלת לב איסכמית, עברה אוטם שריר הלב לפני 5 שנים עישון של חפיסת סיגריות ליום מזה 40 שנה בחודשים האחרונים שמה לב לנפיחות גוברת ברגליים, נפיחות בבטן וקוצר נשימה במאמצים קלים. עלתה 7 ק"ג במשקלה ב- 3 החודשים האחרונים. ובחזרה אל מ.כ....
בבדיקה גופנית Pitting edema of the lower limbs Distended jugular veins Distended abdomen with “ shifting dulness ” Dullness on percussion of right lung
Chest X-rays
בדיקות עזר נוספות אקו לב- –ירידה בינונית בתפקוד חדר שמאל –הרחבת חדר ימין וירידה קשה בתפקודו –יתר לחץ-דם ריאתי איסוף שתן לחלבון ליממה: 6.5 גרם
אבחנות Anasarca IHD, s/p Myocardial infarction Congestive heart failure Pulmonary HT with cor pulmonale Diabetes mellitus type II Nephrotic syndrome
Management Stop smoking Control hyperglycemia Specific therapy for heart failure: –ACE inhibitors – blockers –Diuretic therapy- fusid (consider adding spironolactone) Closely watch urine output, rate of weight reduction, levels of urea & creatinine
Thank you !